Anita Hall, APRN
Psychiatric/Mental Health · Gulfport, MSNPI 1801909916
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 380 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 25.2% of the total. Among psychiatric/mental health clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 380 payments — averaging $20.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$866
- Supernus Pharmaceuticals, Inc.$779
- Axsome Therapeutics, Inc.$499
- Johnson & Johnson$494
- Lundbeck LLC$489
- plus $3K from 19 others
What the payments were for
- Food & beverage$7,743100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 110 | $1,950 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 44 | $866 |
| Supernus Pharmaceuticals, Inc. | 26 | $779 |
| Axsome Therapeutics, Inc. | 16 | $499 |
| Johnson & Johnson | 22 | $494 |
| Lundbeck LLC | 27 | $489 |
| Alkermes, Inc. | 18 | $475 |
| Corium, LLC | 17 | $326 |
| Otsuka America Pharmaceutical, Inc. | 12 | $324 |
| Neurocrine Biosciences, Inc. | 14 | $299 |
| Vanda Pharmaceuticals Inc. | 10 | $258 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $198 |
| Sunovion Pharmaceuticals Inc. | 19 | $155 |
| Teva Pharmaceuticals USA, Inc. | 6 | $115 |
| Jazz Pharmaceuticals Inc. | 6 | $110 |
| Ironshore Pharmaceuticals Inc. | 5 | $92 |
| Eisai Inc. | 5 | $88 |
| E.r. Squibb & Sons, L.L.C. | 2 | $52 |
| Adlon Therapeutics L.p. | 3 | $40 |
| Almatica Pharma LLC | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $25 |
| Sage Therapeutics, LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $18 |
| Tris Pharma Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,749 in reported general payments places this provider in the 95th percentile of 486 psychiatric/mental health providers in Mississippi.
See all psychiatric/mental health providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $92,186 |
| Lurasidone Hcl | 13 | $13,988 |
| Duloxetine Hcl | 39 | $2,387 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $524 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 20 | $465 |
| Gabapentin | 18 | $452 |
| Oxcarbazepine | 13 | $374 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 26 | $331 |
| Divalproex Sodium | 13 | $267 |
| Alprazolam | 14 | $189 |
| Clonazepam | 44 | $147 |
| Trazodone Hcl | 27 | $107 |
| Escitalopram Oxalate | 16 | $103 |
| Sertraline Hcl | 13 | $55 |
| Lamotrigine | 15 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $299 | $92,18612 claims |
| Almatica Pharma LLCSertraline Hcl | $37 | $5513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 486 psychiatric/mental health providers in Mississippi.
Other psychiatric/mental health in Gulfport
- Desiree NormanGulfport$10K
- Tangular BarnesGulfport$9K
- Belinda HoldenGulfport$7K
- Chantal SullivanGulfport$7K
- Anne TuckerGulfport$5K
- Kari WilliamsGulfport$4K
- Jo DrennanGulfport$4K
- Elizabeth GarrigaGulfport$4K
- Ashley KarelVicksburg$129K
- Amanda HamCorinth$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.